Lutetium-177 Lu oxodotreotide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lutetium-177 Lu oxodotreotide, covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors. [Phase 3]